Name: ACCURAY INC (ARAY) Stock
Brand: ACCURAY INC
Rating: 4 (3 reviews)

ARAY Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Benzinga - Mentions: PBM PACB ACHC WORX ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

a month ago - By: Accuray Incorporated

Accuray Reports Fiscal 2026 First Quarter Financial Results

a month ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

a month ago - By: Accuray Incorporated

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

a month ago - By: Accuray Incorporated

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

a month ago - By: Accuray Incorporated

Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth

6 months ago - By: Zacks Investment Research - Mentions: EW

Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

2 months ago - By: Accuray Incorporated

Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System

2 months ago - By: Accuray Incorporated

Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

2 months ago - By: Accuray Incorporated

Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care

3 months ago - By: Accuray Incorporated

Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025

3 months ago - By: Yahoo Finance

Accuray (ARAY) Beats Q4 Revenue Estimates, BTIG Maintains Buy Rating

4 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y

4 months ago - By: The Motley Fool

Accuray Q4 Revenue Hits $128 Million

4 months ago - By: The Motley Fool

Accuray (ARAY) Q4 2025 Earnings Call Transcript

4 months ago - By: Zacks Investment Research - Mentions: PDEX

Accuray (ARAY) Reports Break-Even Earnings for Q4

4 months ago - By: Accuray Incorporated

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

4 months ago - By: Zacks Investment Research - Mentions: NPCE

NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: ASTH

Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates

4 months ago - By: Zacks Investment Research - Mentions: KIDS

OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates

4 months ago - By: Accuray Incorporated

Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025

6 months ago - By: Accuray Incorporated

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

6 months ago - By: Accuray Incorporated

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

7 months ago - By: Zacks Investment Research - Mentions: BSX CVS ITGR

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

7 months ago - By: Accuray Incorporated

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

7 months ago - By: Accuray Incorporated

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

7 months ago - By: Zacks Investment Research - Mentions: MASI FMS AHCO

ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

7 months ago - By: Zacks Investment Research - Mentions: HOLX

Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates

7 months ago - By: Accuray Incorporated

ACCURAY INC (ARAY) Stock News

ARAY Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Accuray Reports Fiscal 2026 First Quarter Financial Results

Earnings Scheduled For November 5, 2025

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth

Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System

Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care

Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025

Accuray (ARAY) Beats Q4 Revenue Estimates, BTIG Maintains Buy Rating

Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y

Accuray Q4 Revenue Hits $128 Million

Accuray (ARAY) Q4 2025 Earnings Call Transcript

Accuray (ARAY) Reports Break-Even Earnings for Q4

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates

Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates

OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates

Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates

Accuray Reports Fiscal 2025 Third Quarter Financial Results